Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

(MedPage Today) — New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide (Nubeqa) in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive…

Source link : https://www.medpagetoday.com/meetingcoverage/auavideopearls/115825

Author :

Publish date : 2025-05-30 17:50:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

CDC Now Advises Shared Decision-Making for Kids’ COVID Shots

COVID Vaccine Guidance in Pregnancy Has Shifted — But the Science Hasn’t

Related Posts

Vaccine Expert: My Grandchild Has Autism, but Vaccines Aren’t to Blame

Vaping Declined in States With Flavor Bans — But It’s Not All Good News

Hospital Refuses to Disable Death Row Inmate’s ICD; Dentist Gets Life Sentence

Ousted Vaccine Panel Members Say Rigorous Science Is Being Abandoned

Trump Overrules RFK Jr.; Giant Earthquake During Cancer Surgery; Ground Beef Recall

Critics of de-extinction research hit by mystery smear campaign

Vaccine Expert: My Grandchild Has Autism, but Vaccines Aren’t to Blame

Vaping Declined in States With Flavor Bans — But It’s Not All Good News

Hospital Refuses to Disable Death Row Inmate’s ICD; Dentist Gets Life Sentence

Ousted Vaccine Panel Members Say Rigorous Science Is Being Abandoned

Trump Overrules RFK Jr.; Giant Earthquake During Cancer Surgery; Ground Beef Recall

Critics of de-extinction research hit by mystery smear campaign

Complex Medical Conditions Drive Children’s Mental Health

Risankizumab Maintains Long-Term Effectiveness in Psoriasis

Categories

Archives